549 related articles for article (PubMed ID: 28931315)
1. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
[TBL] [Abstract][Full Text] [Related]
2. Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs.
Hong H; Thakkar S; Chen M; Tong W
Sci Rep; 2017 Dec; 7(1):17311. PubMed ID: 29229971
[TBL] [Abstract][Full Text] [Related]
3. Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.
Norman BH
J Med Chem; 2020 Oct; 63(20):11397-11419. PubMed ID: 32511920
[TBL] [Abstract][Full Text] [Related]
4. In-silico approach for drug induced liver injury prediction: Recent advances.
Saini N; Bakshi S; Sharma S
Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
[TBL] [Abstract][Full Text] [Related]
5. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity.
Thakkar S; Li T; Liu Z; Wu L; Roberts R; Tong W
Drug Discov Today; 2020 Jan; 25(1):201-208. PubMed ID: 31669330
[TBL] [Abstract][Full Text] [Related]
7. Development of a Battery of
Rathman J; Yang C; Ribeiro JV; Mostrag A; Thakkar S; Tong W; Hobocienski B; Sacher O; Magdziarz T; Bienfait B
Chem Res Toxicol; 2021 Feb; 34(2):601-615. PubMed ID: 33356149
[TBL] [Abstract][Full Text] [Related]
8. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
9. Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs.
Shimizu Y; Sasaki T; Takeshita JI; Watanabe M; Shizu R; Hosaka T; Yoshinari K
PLoS One; 2021; 16(6):e0253855. PubMed ID: 34170966
[TBL] [Abstract][Full Text] [Related]
10. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Aleo MD; Luo Y; Swiss R; Bonin PD; Potter DM; Will Y
Hepatology; 2014 Sep; 60(3):1015-22. PubMed ID: 24799086
[TBL] [Abstract][Full Text] [Related]
11. The liver toxicity knowledge base: a systems approach to a complex end point.
Chen M; Zhang J; Wang Y; Liu Z; Kelly R; Zhou G; Fang H; Borlak J; Tong W
Clin Pharmacol Ther; 2013 May; 93(5):409-12. PubMed ID: 23486446
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity by Drugs: The Most Common Implicated Agents.
Björnsson ES
Int J Mol Sci; 2016 Feb; 17(2):224. PubMed ID: 26861310
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
[TBL] [Abstract][Full Text] [Related]
14. How to Diagnose and Exclude Drug-Induced Liver Injury.
Watkins PB
Dig Dis; 2015; 33(4):472-6. PubMed ID: 26159261
[TBL] [Abstract][Full Text] [Related]
15. Predicting drug-induced liver injury in human with Naïve Bayes classifier approach.
Zhang H; Ding L; Zou Y; Hu SQ; Huang HG; Kong WB; Zhang J
J Comput Aided Mol Des; 2016 Oct; 30(10):889-898. PubMed ID: 27640149
[TBL] [Abstract][Full Text] [Related]
16. Quantitative structure-activity relationship models for predicting drug-induced liver injury based on FDA-approved drug labeling annotation and using a large collection of drugs.
Chen M; Hong H; Fang H; Kelly R; Zhou G; Borlak J; Tong W
Toxicol Sci; 2013 Nov; 136(1):242-9. PubMed ID: 23997115
[TBL] [Abstract][Full Text] [Related]
17. Toward predictive models for drug-induced liver injury in humans: are we there yet?
Chen M; Bisgin H; Tong L; Hong H; Fang H; Borlak J; Tong W
Biomark Med; 2014; 8(2):201-13. PubMed ID: 24521015
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced liver injury: a summary of recent advances.
Stine JG; Lewis JH
Expert Opin Drug Metab Toxicol; 2011 Jul; 7(7):875-90. PubMed ID: 21510822
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
20. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
